Pharmacokinetics and Acceptability of Subcutaneous Injection of Testosterone Undecanoate.
Leo TurnerLam P LyReena DesaiGurmeet K S SinghTimothy D HandelsmanSasha SavkovicCarolyn FennellVeena JayadevAnn ConwayDavid J HandelsmanPublished in: Journal of the Endocrine Society (2019)
We conclude that SC TU injection is acceptable but produces greater pain 24 hours after injection that may contribute to the overall majority preference for the IM injection. The PK of testosterone, DHT, or E2 did not differ substantially between SC and IM routes. Hence whereas further studies are required, the SC route represents an alternative to IM injections without a need to change dose for men for whom IM injection is not desired or recommended.